|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The COX-2 specific inhibitor,rofecoxib, was effective in the treatment of postorthopedic surgical pain显示文摘 | Reicin AS Brown J Jove M | 1999 | Arthritis Rheum1999，42，： | 1 |
| 2 | Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal antiinflammatory drugs(ibuprofen,diclofenac,and nabumetone)显示文摘 | REICIN AS SHAPIRO D SPERLING RS | 2002 | Am J Cardiol2002，89，2： | 1 |
| 3 | Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen,diclofenac,and nabumetone)显示文摘 | Reicin AS Shapiro D Sperling RS | 2002 | Am J Cardiol2002，89，3： | 1 |
| 4 | Rofecoxib demonstrates efficacy and tolerability in children and adolescents with juvenile rheumatoid arthritis in a 12-week randomized stuty显示文摘 | Kiss MH Reiff AA Reicin AS | 2003 | Arthritis Rheum2003，48，： | 1 |
| 5 | Compairson of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs(ibuprofen,diclofenac,and nabumetone)显示文摘 | Reicin AS Shapiro D Sperling RS | 2002 | Am J Cardiol2002，324，7329： | 1 |
| 6 | Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen,diclofenac,and nabumetone)显示文摘 | Shapiro D Sperling RS | 2002 | Am J Cardiol2002，89，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员